Real-time enrollment status for this stargardt disease clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 11:56 PM UTC
| NCT Number | NCT07419334 |
| Recruiting Status | Recruiting |
| Condition | Stargardt Disease |
| Phase | PHASE3 |
| Target Enrollment | 230 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Alkeus Pharmaceuticals, Inc. |
| Last Updated on CT.gov | September 18, 2026 (3 weeks ago) |
As of October 13, 2026: Clinical trial NCT07419334 is currently recruiting participants. This phase3 study for stargardt disease is actively seeking new participants at 14 locations across the United States. The study is sponsored by Alkeus Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07419334 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07419334 was last updated 3 weeks ago (September 18, 2026). HelloStudys verifies this status automatically.